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O
besity, which has reached epidemic propor-
tions in the U.S. and is increasing worldwide, is
closely associated with insulin resistance (pe-
ripheral and hepatic) and with a state of low-
grade inﬂammation, the latter characterized by elevated
levels of proinﬂammatory cytokines in blood and tissues
(1). Insulin resistance and inﬂammation in turn are asso-
ciated with type 2 diabetes, hypertension, atherogenic
dyslipidemias, and disorders of blood coagulation and
ﬁbrinolysis, all of which are independent risk factors for
the development of atherosclerotic vascular disease, in-
cluding heart attacks, strokes, and peripheral arterial
disease (1).
WHAT IS THE CONNECTION BETWEEN OBESITY AND
INSULIN RESISTANCE AND INFLAMMATION?
The reason why obesity is so closely associated with
insulin resistance and inﬂammation is not completely
understood. On one hand, there is evidence to show that
blood levels of free fatty acids (FFAs) play an important
role in the development of obesity-related insulin resis-
tance and inﬂammation (rev. in 2). Plasma FFA levels are
increased in most obese people, and acutely raising
plasma FFA levels increases insulin resistance as well as
the expression of proinﬂammatory cytokines, whereas
lowering plasma FFA levels reduces insulin resistance.
Mechanisms involved in FFA-induced insulin resistance
include accumulation (in muscle and liver) of lipids and
lipid intermediates such as diacylglycerol, activation of
several protein kinase C isoforms, reduction in tyrosine
phosphorylation of the insulin receptor substrates 1 and 2
(2), and activation of the proinﬂammatory nuclear fac-
tor-B pathway (3,4). On the other hand, not all obese
insulin-resistant subjects have elevated plasma FFA levels,
and normalizing the elevated plasma FFA levels in insulin-
resistant obese patients with type 2 diabetes improves but
does not normalize insulin sensitivity (5). This suggests
that there are probably other causes for obesity-related
insulin resistance and inﬂammation. One of these appears
to be endoplasmic reticulum (ER) stress.
WHAT IS ER STRESS AND WHY IS IT SUSPECTED TO
PLAY A ROLE IN OBESITY-ASSOCIATED INSULIN
RESISTANCE AND INFLAMMATION?
The ER is a major site for protein as well as for lipid and
sterol synthesis (6). Ribosomes attached to the ER mem-
branes release newly synthesized peptides into the ER
lumen, where chaperones and foldases assist in the proper
posttranslational modiﬁcation and folding of these pep-
tides (6). The properly folded proteins are then released to
the Golgi complex for further modiﬁcation before they are
transported to their ﬁnal destination. If the inﬂux of
misfolded or unfolded peptides exceeds the ER folding
and/or processing capacity, ER stress ensues. Three proxi-
mal ER stress sensors have been identiﬁed. They are inositol-
requiring enzyme (IRE)-1, PKR-like ER-regulating kinase
(PERK), and activating transcription factor (ATF)-6. These
sensors trigger activation of pathways that alleviate ER
stress, termed the unfolded protein response. The un-
folded protein response can achieve this by slowing pro-
tein synthesis and/or by turning up the production of
protein chaperones needed for proper protein folding or, if
unsuccessful, by degrading the unfolded proteins (6).
Excess nutrient intake is the main cause for obesity, and
several recent studies have implicated ER stress as an
early consequence of nutrient excess and a cause for the
development of insulin resistance and inﬂammation. For
instance, chronic excess nutrient intake has been shown
to cause ER stress as well as insulin resistance and
inﬂammation in adipose tissue of ob/ob mice and in mice
fed high-fat diets, whereas overexpression of some chap-
erone genes or administration of chaperone proteins re-
duced ER stress, insulin resistance, and inﬂammation in
rodents (rev. in 7). Furthermore, it has been recently
shown that ER stress is increased in subcutaneous fat of
obese human subjects (8).
The cause for increased ER stress in fat is not known,
but based on animal data, excess nutrient intake appears
to be a likely possibility. The adipose tissue has to take up
and store excess calories as fat and, hence, needs to
synthesize many proteins to meet this challenge. In addi-
tion, the massive expansion of adipose tissue requires
synthesis of structural proteins. Fatty acids, which are an
important part of overnutrition and which have been
shown to induce ER stress in cultured hepatocytes and
pancreatic -cells (9), are likely to be among the agents
causing ER stress.
HOW CAN ER STRESS CAUSE INSULIN RESISTANCE
AND INFLAMMATION?
ER stress has been demonstrated to trigger activation of
several serine/threonine kinases, including c-jun NH2-ter-
minal kinase (JNK) and IB- kinase (IKK). For instance,
ER stress leads to formation of the IRE-1-TRAF 2 com-
plex, which results in phosphorylation and activation of
From the Division of Endocrinology, Diabetes, and Metabolism, Temple
University School of Medicine, Philadelphia, Pennsylvania.
Corresponding author: Guenther Boden, bodengh@tuhs.temple.edu.
DOI: 10.2337/db08-1746
© 2009 by the American Diabetes Association. Readers may use this article as
long as the work is properly cited, the use is educational and not for proﬁt,
and the work is not altered. See http://creativecommons.org/licenses/by
-nc-nd/3.0/ for details.
See accompanying original article, p. 693.
COMMENTARY
518 DIABETES, VOL. 58, MARCH 2009IKK. IKK phosphorylates and inactivates IB-, resulting
in activation and nuclear translocation of nuclear factor 
B, which is a key promoter of inﬂammation (10). The
IRE-1-TRAF 2 complex also phosphorylates and activates
JNK, which induces the expression of proinﬂammatory
cytokines and induces insulin resistance via serine phos-
phorylation of insulin receptor substrates 1 and 2 (11).
ER stress is also a major source for the production of
reactive oxygen species (ROS). This can occur via activa-
tion of protein disulﬁde isomerase (PDI), an enzyme which
catalyzes disulﬁde bridge formation and in the process
generates ROS. ROS are known to promote insulin resis-
tance and inﬂammation (6,10). Thus, the ER may be a
proximal site that senses nutritional excess and translates
it into metabolic and inﬂammatory responses.
ER STRESS IN HUMAN ADIPOSE TISSUE
Several recent reports support the concept of a close
dynamic relationship between obesity and ER stress in
human subjects. Thus, ER stress has been demonstrated in
adipose tissue of obese insulin-resistant nondiabetic sub-
jects (8,12), and in this issue of Diabetes Gregor et al.
describe the effects of bariatric surgery on ER stress (13).
These authors studied 11 obese men and women before
and again 1 year after gastric bypass (Roux-en-Y) surgery.
They found that several markers of ER stress including
GRP78 and XBP1s mRNA and the phosphorylated forms of
eIF2 and JNK-1 proteins all had decreased signiﬁcantly 1
year after surgery, while liver biopsies from a subset of
four patients showed reduced staining for GRP78 and
eIF2 proteins (13).
As is often the case, these interesting ﬁndings raise new
questions. Most importantly, it would be important to
know what was responsible for the decrease in ER stress
in these obese individuals after surgery. Was it the de-
crease in nutrient intake resulting in reduced oxidative
stress and reduced need to synthesize proteins to metab-
olize and store excess calories? Early measurements,
before signiﬁcant weight loss occurred, would have been
helpful to answer this question. Or was it the loss of
adipose tissue and an associated decrease in the release of
adipokines and FFAs? Supporting that possibility was the
ﬁnding that ER stress, albeit reduced, was still present 1
year after surgery even though caloric intake was presum-
ably below normal. Or, what seems likely, was it a
combination of both? Also, did the decrease in ER stress
contribute to the decrease in insulin resistance and, if so,
by what mechanism? Thus, there remain many unan-
swered questions. However, this is a new ﬁeld of research,
which is attracting much attention, and therefore it can be
expected that many of these questions will soon be
addressed in other studies.
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